Home » Topics » Regulatory

Regulatory
RSS

Novartis receives first approval for Gilenya MS therapy in Russia

Sep. 10, 2010

E.U. approves Brinavess for rapid conversion of recent-onset AF

Sep. 3, 2010

FDA approves Novartis' Tekamlo for hypertension

Aug. 27, 2010

Takepron approved for additional indication in Japan

Aug. 24, 2010

Precedex IV 200 mcg approved for long-term use in Japan

Aug. 23, 2010

FDA approves new docetaxel injection concentrate formulation for cancer

Aug. 6, 2010

FDA accepts NDA for gadobutrol injection in MRI of CNS

Aug. 6, 2010

FDA approves two new dose strengths of niacin/simvastatin

July 29, 2010

FDA approves Cuvposa for chronic drooling in children with neurological disorders

July 29, 2010

FDA approves Daiichi Sankyo's Tribenzor for hypertension

July 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...